Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Eureka Genomics' EG-Human ID Barcode; Illumina's Nextera Rapid Capture Assay

Premium

Eureka Genomics has launched a human identification service called EG-Human ID Barcode. The test is available as a service to researchers and CROs, and will be available as a kit in the third quarter of this year. The service is based on next-generation sequencing and comprises 94 SNPs and one gender marker. According to the company, it can work with DNA from primary tissues, cell lines, cytoswabs, and formalin-fixed paraffin-embedded samples. The kits can run on Illumina or Life Technologies' Ion Torrent platforms.


Illumina has launched Nextera Rapid Capture Custom Enrichment assay, which enables researchers to design custom capture content between 0.5 megabase pairs to 15 megabase pairs in a single assay with 50 nanograms of input DNA. The kit can also be used to add content to existing panels, such as the Nextera Rapid Capture Exome or TruSight content sets, according to the company.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.